Progyny Inc (PGNY) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]
Progyny, Inc. (PGNY)
Last progyny, inc. earnings: 3/5 04:06 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Medical Revenue (Q4 2024): $188 million, up 9.4% year-over-year. Pharmacy Revenue (Q4 2024): $111 million, up 13% year-over-year. Gross Margin (Q4 2024): 21.3%, slight improvement from the previous year. Adjusted EBITDA (Q4 2024): $47.5 million, up 10% year-over-year, with a margin of 15.9%. Net Income (Q4 2024): $10.5 million or $0.11 per diluted share. Adjusted EPS (Q4 2024): $0.42, compared to $0.32 in the previous year. Operating Cash Flow (Q4 2024): $52.2 million, compared to $37.7 million in the previous year. Clients and Covered Lives (End of 2024): 530 clients and 6.7 million covered lives. ART Cycles (Q4 2024): More than 15,800 cycles, highest quarterly total ever. Female Utilization (Q4 2024): 0.48%, consistent with the previous year. Cash and Equivalents (End of 2024): $228 million, with no debt. Warning! GuruFocus has detected 2 Warning Sign with PGNY. Release Date: February 27, 2025 For the complete transcript of the earnings call, please refer
Show less
Read more
Impact Snapshot
Event Time:
PGNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGNY alerts
High impacting Progyny, Inc. news events
Weekly update
A roundup of the hottest topics
PGNY
News
- Progyny (NASDAQ:PGNY) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.MarketBeat
- Progyny (NASDAQ:PGNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.MarketBeat
- Progyny (PGNY): Reassessing Valuation After a Strong Year and Recent Pullback in the Share Price [Yahoo! Finance]Yahoo! Finance
- Progyny (PGNY) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and ActionGlobeNewswire
PGNY
Earnings
- 11/6/25 - Beat
PGNY
Sec Filings
- 12/11/25 - Form 144
- 12/8/25 - Form 4
- 12/8/25 - Form 4
- PGNY's page on the SEC website